Fed Circuit revives bid to invalidate robotic surgery patent
The US Court of Appeals for the Federal Circuit has renewed Auris Health’s attempt to invalidate Intuitive Surgical’s patent covering a robotic surgical tool.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
24 August 2021 The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision.
15 February 2022 The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.
15 February 2022 The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.
24 August 2021 The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision.
15 February 2022 The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.
24 August 2021 The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision.